Junping Pei
Impact in
-
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
- Melanoma and MAPK Pathways
-
- Peptidase Inhibition and Analysis
Papers in
-
- Protein Degradation and Inhibitors 4
- Ubiquitin and proteasome pathways 3
- Melanoma and MAPK Pathways 2
- Oncology 7
- Colorectal Cancer Treatments and Studies 2
- Peptidase Inhibition and Analysis 2
- Co-authors
- Liang Ouyang (11 shared papers)Guan Wang (10 shared papers)Lu Feng (4 shared papers)Jifa Zhang (2 shared papers)Tingting Jiang (2 shared papers)Yuxi Wang (4 shared papers)Shuai Wen (6 shared papers)Faqian Bu (4 shared papers)
- Journals
- Journal of Medicinal Chemistry (7 papers)Organic Letters (3 papers)Organic Chemistry Frontiers (2 papers)Acta Pharmaceutica Sinica B (2 papers)Chemical Communications (2 papers)
- Partner nations
- ChinaThailandNew Zealand
In The Last Decade
Junping Pei
22 papers receiving 515 citations
Peers
Comparison fields: 5 of 81
- Molecular Biology 316
- Oncology 117
- Organic Chemistry 112
- Physiology 15
- Neurology 44
Countries citing papers authored by Junping Pei
This map shows the geographic impact of Junping Pei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junping Pei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junping Pei more than expected).
Fields of papers citing papers by Junping Pei
This network shows the impact of papers produced by Junping Pei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junping Pei. The network helps show where Junping Pei may publish in the future.
Co-authors
The 25 scholars most cited alongside Junping Pei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 103 | |
| 2 | 2021 | 93 | |
| 3 | 2021 | 87 | |
| 4 | 2021 | 60 | |
| 5 | 2022 | 50 | |
| 6 | 2019 | 20 | |
| 7 | 2022 | 18 | |
| 8 | 2018 | 16 | |
| 9 | 2021 | 16 | |
| 10 | 2021 | 15 | |
| 11 | 2021 | 9 | |
| 12 | 2023 | 9 | |
| 13 | 2020 | 8 | |
| 14 | 2024 | 4 | |
| 15 | 2024 | 3 | |
| 16 | 2025 | 3 | |
| 17 | [CHRONIC CONTINUOUS NOR-MOBARIC HYPOXIA AUGMENTS CELL TOLERANCE TO ANOXIA(REOXYGE-NATION: THE ROLE OF PROTEIN KINASES]. | 2016 | 3 |
| 18 | 2024 | 2 | |
| 19 | 2025 | 1 | |
| 20 | 2022 | 1 |
About Junping Pei
Junping Pei is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Pulmonary and Respiratory Medicine and Computational Theory and Mathematics, having authored 24 papers that have together received 523 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (4 papers), Lung Cancer Treatments and Mutations (4 papers), Asymmetric Synthesis and Catalysis (4 papers), Computational Drug Discovery Methods (3 papers), Ubiquitin and proteasome pathways (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Peptidase Inhibition and Analysis (2 papers) and Melanoma and MAPK Pathways (2 papers). The work is most often cited by research in Molecular Biology (316 citations), Oncology (117 citations), Organic Chemistry (112 citations), Physiology (15 citations) and Neurology (44 citations). Junping Pei has collaborated with scholars based in China, Thailand and New Zealand. Frequent co-authors include Liang Ouyang, Guan Wang, Lu Feng, Jifa Zhang, Tingting Jiang, Yuxi Wang, Shuai Wen, Faqian Bu, Weimin Li and Jiaxing Wang. Their work appears in journals such as Journal of Medicinal Chemistry, Organic Letters, Organic Chemistry Frontiers, Acta Pharmaceutica Sinica B and Chemical Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.